PAVmed (PAVM) Liabilities and Shareholders Equity (2015 - 2026)
PAVmed (PAVM) posted quarterly Liabilities and Shareholders Equity of $38.8 million for Q4 2025, up 26.59% year-over-year from $30.7 million in Q4 2024, and up 1.95% quarter-over-quarter from $38.1 million in Q3 2025.
PAVmed (PAVM) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
PAVmed's Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $38.8 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 26.59% year-over-year to $38.8 million; the TTM figure through Dec 2025 stood at $173.6 million (up 31.14% YoY), while the FY2025 annual figure was $38.8 million, up 26.59% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $38.8 million, up from $38.1 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $87.0 million in Q4 2021, with the low at $25.0 million in Q3 2024.
- The 5-year median for Liabilities and Shareholders Equity is $45.6 million (2021), against an average of $51.1 million.
- The sharpest annual moves came in 2021 and 2024: Liabilities and Shareholders Equity jumped 433.34% in 2021, then plunged 42.94% in 2024.
- PAVmed's Liabilities and Shareholders Equity stood at $87.0 million in 2021, then slumped by 37.94% to $54.0 million in 2022, then sank by 38.65% to $33.1 million in 2023, then fell by 7.42% to $30.7 million in 2024, then climbed by 26.59% to $38.8 million in 2025.
- Business Quant data shows PAVM's Liabilities and Shareholders Equity at $38.8 million in Q4 2025, $38.1 million in Q3 2025, and $43.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 10.74 Bn |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | 40.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.21 Mn |
| Dec 31, 2025 | 38.81 Mn |
| Sep 30, 2025 | 38.07 Mn |
| Jun 30, 2025 | 43.89 Mn |
| Mar 31, 2025 | 52.82 Mn |
| Dec 31, 2024 | 30.66 Mn |
| Sep 10, 2024 | 25.04 Mn |
| Jun 30, 2024 | 39.41 Mn |
| Mar 31, 2024 | 37.25 Mn |
| Dec 31, 2023 | 33.12 Mn |
| Sep 30, 2023 | 42.02 Mn |
| Jun 30, 2023 | 53.68 Mn |
| Mar 31, 2023 | 65.29 Mn |
| Dec 31, 2022 | 53.98 Mn |
| Sep 30, 2022 | 72.47 Mn |
| Jun 30, 2022 | 82.45 Mn |
| Mar 31, 2022 | 84.33 Mn |
| Dec 31, 2021 | 86.98 Mn |
| Sep 30, 2021 | 42.99 Mn |
| Jun 30, 2021 | 47.37 Mn |